Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Bidentate Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111203276B reveals a manganese-catalyzed hydrosilylation method for high-purity chiral silanes, offering significant cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN102464681A discloses a stable chiral bidentate phosphite ligand for asymmetric synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN102464672A discloses a novel mannitol-based ligand for asymmetric catalysis, offering high enantioselectivity and simplified synthesis for cost-effective pharmaceutical manufacturing.
Patent CN110845547A details novel Pd-catalyzed asymmetric alkylation. Offers high ee values and mild conditions for indole derivatives manufacturing.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.